- NCIt
- C200227
Loading cancer entity…
Loading cancer entity…
Clinical trials
51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04207944 | The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) | active not recruiting | Phase 2 | 100 | Duke UniversityOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT03729453 | Intra-operative Pancreatoscopy in Patients With IPMN | active not recruiting | — | 100 | Boston Scientific CorporationINDUSTRY | 6 | Jul 24, 2026 | clinicaltrials |
| NCT02757859 |
| WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer |
| active not recruiting |
| N/A |
| 845 |
| Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER |
| 1 |
| May 29, 2026 |
| clinicaltrials |
| NCT06712797 | Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center(PANTHER-PIC) | active not recruiting | N/A | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT06519097 | Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) | active not recruiting | Phase 2 | 4 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 13, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Sep 8, 2026source: clinicaltrials